Intact Vascular has announced the peer-reviewed publication, “Practical applications of Tack implants for infrainguinal dissection repair: A single-centre experience” currently available online, with the article scheduled to be published in the February 2020 issue of Journal of Endovascular Therapy.
The publication highlights practical experience with the Tack Endovascular System following its European launch in January 2019. The first-of-its kind dissection repair device was implanted in patients who underwent balloon angioplasty as part of endovascular revascularisation for peripheral arterial disease or critical limb ischemia and subsequently experienced post-angioplasty dissection. A total of 63 dissections were evenly distributed above and below the knee and exhibited characteristics representative of real-world clinical applications. Tack implants were deployed to treat 95.2% of these dissections, using the above-the-knee (ATK) system for femoropopliteal dissections and the below-the-knee (BTK) system for infrapopliteal dissections.
“With a 98.3% technical success rate, this study demonstrates the practical application of the Tack implants in real-world lesions, completely resolving 59 of 60 dissections with no major adverse events and no device-related complications during the procedure,” commented Michael KW Lichtenberg, chief of Angiology Clinic and Venous Center, Klinikum Arnsberg in Germany, and lead author of the article. “I am pleased with our experience using the Tack System, including cases with complex lesions. This technology is extremely impressive, and I look forward to continued use in my above- and below-the-knee treatment algorithms.”
Established endovascular revascularisation methods, including plain and drug-coated balloon angioplasty, atherectomy and lithotripsy, frequently result in arterial dissections. Often overlooked, underdiagnosed and left untreated, these dissections can lead to acute procedural complications or restenosis, requiring reintervention and potentially limiting future treatment options.1
“We are very pleased to have the results of this clinical investigation published in the Journal of Endovascular Therapy,” commented Peter Schneider, co-founder and chief medical officer of Intact Vascular. “Under challenging real-world conditions, the Tack implants performed as designed. These data further validate use of this novel technology, across all lower extremity vascular beds, to resolve dissections without complications and to improve outcomes of standard endovascular procedures.”
